Open AccessOral Insulin Secretagogues, Insulin, and Cancer Risk in Type 2 Diabetes Mellitus
Author(s) -
ChiaHsuin Chang,
JouWei Lin,
LiChiu Wu,
MeiShu Lai,
LeeMing Chuang
Publication year - 2012
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2012-1162
Subject(s) - medicine , hyperinsulinemia , odds ratio , cancer , diabetes mellitus , insulin , type 2 diabetes , incidence (geometry) , sulfonylurea , endocrinology , pancreatic cancer , insulin resistance , physics , optics
Hyperinsulinemia might be the mechanism leading to an increased cancer risk in patients with type 2 diabetes. The objective was to evaluate the association between oral insulin secretagogues, insulins, and cancer incidence.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom